STTK ranks #4512 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.
STTK is a top-conviction position for NEXTBio Capital Management LP — at 11.9% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.
The largest dollar stake in STTK belongs to T. Rowe Price Investment Management, Inc., but the position matters far more to NEXTBio Capital Management LP, who has 11.9% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.
Mallini Complete Financial Planning LLC has added to its STTK position for two straight quarters, increasing it by $12.2K to reach $157.8K today.
STTK is down 9.9% today, but institutions show net buying of $211.5M this quarter — a divergence between today's price move and the underlying institutional flow.